Ohana Patricia 4
4 · BIOCANCELL THERAPEUTICS INC. · Filed Mar 8, 2011
Insider Transaction Report
Form 4
BIOCANCELL THERAPEUTICS INC.BICL.TA
Ohana Patricia
VP of Clinical Development
Transactions
- Award
Employee Options
2011-03-06+70,888→ 290,888 totalExp: 2021-03-06→ Common Stock (70,888 underlying)
Footnotes (2)
- [F1]The exercise price is 2.85 NIS per share.
- [F2]An option to purchase 13,293 shares shall be exercisable immediately, and an option to purchase 4,431 shares shall be exercisable at the end of each calendar quarter, from March 31, 2011 until March 31, 2014.